{"id":"https://genegraph.clinicalgenome.org/r/ee1a37bd-11a8-4e4c-880b-5abec2f22bd7v3.0","type":"EvidenceStrengthAssertion","dc:description":"MSH3 was first reported in relation to autosomal recessive familial adenomatous polyposis 4 in 2016 (Adam et al., PMID: 27476653). MSH3-related familial adenomatous polyposis 4 is characterized by attenuated polyposis and increased susceptibility to colorectal cancer. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in inheritance pattern and phenotypic variability. Therefore, the gene-disease relationship between MSH3 - Lynch syndrome (MONDO:0005835) and autosomal recessive FAP4 was curated separately. Nineteen variants (nonsense, frameshift, large deletion, splicing, missense) that have been reported in 10 probands in 6 publications (PMIDs 27476653, 37597744, 35675019, 38243056, 34250384, 37402566) are included in this curation. The mechanism of pathogenicity is known to be loss of function. This gene-disease relationship is also supported by expression studies, in vitro functional assays, and animal models (PMIDs: 18922920, 24013230, 10706084, 27476653). These studies show that biallelic loss of MSH3 leads to impaired DNA double strand break repair and formation of presumably microsatellite-stable adenomas that contain a unique EMAST signature (a distinct form of microsatellite instability). Knockout mouse models display increased intestinal tumor formation. In summary, there is definitive evidence supporting the relationship between MSH3 and autosomal recessive familial adenomatous polyposis 4. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This gene-disease pair was originally evaluated as Moderate by the Hereditary Cancer GCEP on March 6, 2024. This re-curation at Definitive was approved by the ClinGen Hereditary Cancer GCEP on May 24, 2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/ee1a37bd-11a8-4e4c-880b-5abec2f22bd7","GCISnapshot":"https://genegraph.clinicalgenome.org/r/3ec777aa-af6a-4cc6-ace1-b22e4b493457","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/3ec777aa-af6a-4cc6-ace1-b22e4b493457_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2024-08-29T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/3ec777aa-af6a-4cc6-ace1-b22e4b493457_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2024-08-29T20:15:30.236Z","role":"Publisher"}],"curationReasonDescription":"Multiple replicated reports","curationReasons":["RecurationNewEvidence","ErrorClarification","DiseaseNameUpdate"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3ec777aa-af6a-4cc6-ace1-b22e4b493457_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74fb9987-23dc-4943-9e88-88bab9b269ae_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74fb9987-23dc-4943-9e88-88bab9b269ae","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476653","rdfs:label":"II-2","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":32,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/5fd768d0-fda6-4b91-b323-9b79c56bc535","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002439.5(MSH3):c.2760del (p.Tyr921fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3328349"}},{"id":"https://genegraph.clinicalgenome.org/r/16df2c51-51c8-43e4-8657-2922aea02076","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002439.5(MSH3):c.2319-1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10586320"}}],"detectionMethod":"Germ-line SNV and CNVs in APC or MUTYH were ruled out. Additionally, the two hotspot mutations in POLE and POLD1 were excluded.\n","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Duodenal adenoma","phenotypes":["obo:HP_0009592","obo:HP_0000854","obo:HP_0005227","obo:HP_0012740"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/674e5569-3613-4e6a-bb61-10671da83ef5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476653","allele":{"id":"https://genegraph.clinicalgenome.org/r/16df2c51-51c8-43e4-8657-2922aea02076"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/a3f25e14-03d3-45ef-ba29-9d1b8e3d9bae_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476653","allele":{"id":"https://genegraph.clinicalgenome.org/r/5fd768d0-fda6-4b91-b323-9b79c56bc535"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/674e5569-3613-4e6a-bb61-10671da83ef5","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/674e5569-3613-4e6a-bb61-10671da83ef5_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/674e5569-3613-4e6a-bb61-10671da83ef5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"RT-PCR showed 2 bands on an agarose gel. Sequencing of the shortened transcript confirmed a loss of exon 17, which is predicted to result in an in-frame loss of 39 amino acids (774–812) at the protein level. These amino acids are involved in DNA recognition. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a3f25e14-03d3-45ef-ba29-9d1b8e3d9bae","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a3f25e14-03d3-45ef-ba29-9d1b8e3d9bae_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/a3f25e14-03d3-45ef-ba29-9d1b8e3d9bae_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variant expressed in HEK293T cells and showed by western blot that protein was shortened by expected length.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/1d2591b2-4648-4558-9945-f7d47daa89cf_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1d2591b2-4648-4558-9945-f7d47daa89cf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37402566","rdfs:label":"P4 Villy","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":32,"allele":{"id":"https://genegraph.clinicalgenome.org/r/66c35aed-7a8b-4935-8f0a-9733af5f80ad","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002439.5(MSH3):c.580-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3327646"}},"detectionMethod":"NGS, MGPT and negative for all other known polyposis-related genes.","firstTestingMethod":"Next generation sequencing panels","phenotypes":"obo:HP_0200063","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/417b2d30-6909-40d4-8990-e17c14f6ea2c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37402566","allele":{"id":"https://genegraph.clinicalgenome.org/r/66c35aed-7a8b-4935-8f0a-9733af5f80ad"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/417b2d30-6909-40d4-8990-e17c14f6ea2c","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/417b2d30-6909-40d4-8990-e17c14f6ea2c_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/417b2d30-6909-40d4-8990-e17c14f6ea2c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"RNA data showed exon skipping; deletion is in-frame and not expected to undergo NMD","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/29b43177-9e84-4cde-8d52-46fa94df1f4a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/29b43177-9e84-4cde-8d52-46fa94df1f4a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35675019","rdfs:label":"P1 Aelvoet","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":43,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/2d666466-f0cc-41d6-a1c6-02d66d39116f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000005.9:g.(?_80021262)_(80088673_?)del","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1458056"}},{"id":"https://genegraph.clinicalgenome.org/r/799f1940-a136-4b68-853e-49f54c96dd4a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002439.5(MSH3):c.2409C>A (p.Cys803del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA360281882"}}],"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"95% adenomatous, 3% sessile serrated, 1% hyperplastic","phenotypes":["obo:HP_0200063","obo:HP_0003002"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/3a1a6645-9065-45ca-836d-4c188a2ca48b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35675019","allele":{"id":"https://genegraph.clinicalgenome.org/r/2d666466-f0cc-41d6-a1c6-02d66d39116f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/54bc3f26-7374-481d-8c78-c4b1169e2e4b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35675019","allele":{"id":"https://genegraph.clinicalgenome.org/r/799f1940-a136-4b68-853e-49f54c96dd4a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/3a1a6645-9065-45ca-836d-4c188a2ca48b","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3a1a6645-9065-45ca-836d-4c188a2ca48b_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/54bc3f26-7374-481d-8c78-c4b1169e2e4b","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/54bc3f26-7374-481d-8c78-c4b1169e2e4b_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/54bc3f26-7374-481d-8c78-c4b1169e2e4b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"NMD prone","functionalDataSupport":"No"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/3ec777aa-af6a-4cc6-ace1-b22e4b493457_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f5df4eee-8a04-4a84-b5a8-f03eaaf797ba_proband_segregation","type":"FamilyCosegregation","dc:description":"Per SOP: need 3 affected individuals to use family for AR LOD score calculation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476653","rdfs:label":"1275","estimatedLodScore":0.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/f5df4eee-8a04-4a84-b5a8-f03eaaf797ba","type":"Family","rdfs:label":"1275","member":{"id":"https://genegraph.clinicalgenome.org/r/cba979b5-9538-44da-ab64-9c3e34326d47","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476653","rdfs:label":"II-4","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":36,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/05df2956-0730-486a-a97f-3db44f8a2137","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002439.5(MSH3):c.1148del (p.Lys383fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA119871"}},{"id":"https://genegraph.clinicalgenome.org/r/d8e18b77-2e8d-40d1-b93a-fa7524733fef","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002439.5(MSH3):c.3001-2A>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10586319"}}],"detectionMethod":"Germ-line SNV and CNVs in APC or MUTYH were ruled out. Additionally, the two hotspot mutations in POLE and POLD1 were excluded.","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Duodenal adenoma, intraductal papillomas of mammary glands","phenotypes":["obo:HP_0000131","obo:HP_0005227","obo:HP_0000854"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/bac65eb9-f982-4c77-afcf-326fc22460e9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476653","allele":{"id":"https://genegraph.clinicalgenome.org/r/05df2956-0730-486a-a97f-3db44f8a2137"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/92c06776-2393-4d2a-a178-5941da1550a3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476653","allele":{"id":"https://genegraph.clinicalgenome.org/r/d8e18b77-2e8d-40d1-b93a-fa7524733fef"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Duodenal adenoma","phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0005227","proband":{"id":"https://genegraph.clinicalgenome.org/r/cba979b5-9538-44da-ab64-9c3e34326d47"}},{"id":"https://genegraph.clinicalgenome.org/r/7e6b1fd2-f58c-4992-9a9e-c384ab77735a_proband_segregation","type":"FamilyCosegregation","dc:description":"Per SOP: need 3 affected individuals to use family in AR LOD score calculation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476653","rdfs:label":"1661","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/7e6b1fd2-f58c-4992-9a9e-c384ab77735a","type":"Family","rdfs:label":"1661","member":{"id":"https://genegraph.clinicalgenome.org/r/74fb9987-23dc-4943-9e88-88bab9b269ae"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0005227","proband":{"id":"https://genegraph.clinicalgenome.org/r/74fb9987-23dc-4943-9e88-88bab9b269ae"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/079013ab-45eb-403b-bca6-3416d7a55db5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/079013ab-45eb-403b-bca6-3416d7a55db5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37402566","rdfs:label":"P5 Villy","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":36,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/192b490c-35b3-4781-9e05-e305c72b658c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002439.5(MSH3):c.2713T>G (p.Tyr905Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA360273925"}},{"id":"https://genegraph.clinicalgenome.org/r/a6cb8619-d2a1-4141-a490-938e6f409a85","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002439.5(MSH3):c.1421_1422del (p.Glu474ValfsTer8)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3327900"}}],"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Though polyps reported are hyperplastic, tumor studies confirmed EMAST signature, associated with MSH3 biallelic pathogenic variants.","phenotypes":["obo:HP_0200063","obo:HP_0012183"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/0049ca41-dc46-4340-af5a-7df75ea8cd96_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37402566","allele":{"id":"https://genegraph.clinicalgenome.org/r/a6cb8619-d2a1-4141-a490-938e6f409a85"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/72270b15-98a2-419e-9811-854a3b7c3cbd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37402566","allele":{"id":"https://genegraph.clinicalgenome.org/r/192b490c-35b3-4781-9e05-e305c72b658c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/0049ca41-dc46-4340-af5a-7df75ea8cd96","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0049ca41-dc46-4340-af5a-7df75ea8cd96_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/72270b15-98a2-419e-9811-854a3b7c3cbd","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/72270b15-98a2-419e-9811-854a3b7c3cbd_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/651e14c2-7c10-4408-94e7-3aa8e498f4c6_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/651e14c2-7c10-4408-94e7-3aa8e498f4c6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37402566","rdfs:label":"P2 Villy","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":45,"allele":{"id":"https://genegraph.clinicalgenome.org/r/329f6afc-b595-4cdc-a7f7-be69a2fcf6e0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002439.5(MSH3):c.2454T>A (p.Tyr818del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA360283016"}},"firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0003003","obo:HP_0003002","obo:HP_0200063"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/c6325f2e-8524-4b89-ac46-75576d7a4b81_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37402566","allele":{"id":"https://genegraph.clinicalgenome.org/r/329f6afc-b595-4cdc-a7f7-be69a2fcf6e0"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/c6325f2e-8524-4b89-ac46-75576d7a4b81","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6325f2e-8524-4b89-ac46-75576d7a4b81_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/cba979b5-9538-44da-ab64-9c3e34326d47_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cba979b5-9538-44da-ab64-9c3e34326d47"},{"id":"https://genegraph.clinicalgenome.org/r/bac65eb9-f982-4c77-afcf-326fc22460e9","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bac65eb9-f982-4c77-afcf-326fc22460e9_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/bac65eb9-f982-4c77-afcf-326fc22460e9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variant expressed in HEK293T cells. Western blot showed that protein was shortened by expected length.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/92c06776-2393-4d2a-a178-5941da1550a3","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/92c06776-2393-4d2a-a178-5941da1550a3_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/92c06776-2393-4d2a-a178-5941da1550a3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"RT-PCR showed 2 bands on an agarose gel. Sequencing of the shortened transcript confirmed a loss of exon 22. This is predicted to result in a frameshift mutation with a premature stop codon after 16 amino acids, altering the dimerization domain.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/086aa70a-fe20-4879-aa71-0cb2a45ecbab_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/086aa70a-fe20-4879-aa71-0cb2a45ecbab","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38243056","rdfs:label":"P1 Koi","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":43,"allele":{"id":"https://genegraph.clinicalgenome.org/r/9a4e3e41-4ee6-4822-8fdc-9678f6564f5e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002439.5(MSH3):c.2436-1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3328260"}},"detectionMethod":"55 gene panel","firstTestingMethod":"Next generation sequencing panels","phenotypes":"obo:HP_0003003","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/47d5088a-c8d9-4ed7-a75f-abd4ce881479_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38243056","allele":{"id":"https://genegraph.clinicalgenome.org/r/9a4e3e41-4ee6-4822-8fdc-9678f6564f5e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}},{"id":"https://genegraph.clinicalgenome.org/r/47d5088a-c8d9-4ed7-a75f-abd4ce881479","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/47d5088a-c8d9-4ed7-a75f-abd4ce881479_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/47d5088a-c8d9-4ed7-a75f-abd4ce881479_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"RE-PCR confirmed exon deletion and resultant frameshift with premature stop codon.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a7ea82f5-9cd3-4088-a7ff-31c239425a01_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a7ea82f5-9cd3-4088-a7ff-31c239425a01","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34250384","rdfs:label":"1M","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":70,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/9075b552-016f-4575-a784-4f4fb8d891a8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002439.5(MSH3):c.3130+3A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/666138"}},{"id":"https://genegraph.clinicalgenome.org/r/1f95adb7-eabb-4e86-b9f0-84c155d024e6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002439.5(MSH3):c.978_984del (p.Phe326fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/657893"}}],"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Endometrial cancer, microsatellite stable ","phenotypes":["obo:HP_0003002","obo:HP_0200063"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/ff264f3a-0d7b-43bd-b1dc-399a2db39723_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34250384","allele":{"id":"https://genegraph.clinicalgenome.org/r/1f95adb7-eabb-4e86-b9f0-84c155d024e6"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/f52fa948-7757-4c36-8331-3f4c5918058c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34250384","allele":{"id":"https://genegraph.clinicalgenome.org/r/9075b552-016f-4575-a784-4f4fb8d891a8"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/ff264f3a-0d7b-43bd-b1dc-399a2db39723","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ff264f3a-0d7b-43bd-b1dc-399a2db39723_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/f52fa948-7757-4c36-8331-3f4c5918058c","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f52fa948-7757-4c36-8331-3f4c5918058c_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/171eadf9-bcee-43de-9293-d5bb5ca22862_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/171eadf9-bcee-43de-9293-d5bb5ca22862","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37402566","rdfs:label":"P1 Villy","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":39,"allele":{"id":"https://genegraph.clinicalgenome.org/r/a7cf3035-b2a0-4dff-929e-75cda56db564","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002439.5(MSH3):c.2421G>A (p.Trp807del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA360281912"}},"detectionMethod":"Multigene panel, other causes of CRC or polyposis negative","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0100526","obo:HP_0200063","obo:HP_0005562","obo:HP_0003003"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/44a77c4b-10b4-48f1-9cde-aa018645265e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37402566","allele":{"id":"https://genegraph.clinicalgenome.org/r/a7cf3035-b2a0-4dff-929e-75cda56db564"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/44a77c4b-10b4-48f1-9cde-aa018645265e","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/44a77c4b-10b4-48f1-9cde-aa018645265e_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/7bb58785-2734-419c-a941-62164d714321_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7bb58785-2734-419c-a941-62164d714321","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37597744","rdfs:label":"P1 Gavric","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":40,"allele":{"id":"https://genegraph.clinicalgenome.org/r/38faa482-42ac-427a-a0d0-c978bad17459","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000005.10:g.(?_80775684)_(80775768_?)del","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/665026"}},"firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0003002","obo:HP_0001407","obo:HP_0200063","obo:HP_0005562"],"previousTesting":true,"previousTestingDescription":"HBOC multigene panel negative","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/1c08ceb9-91e5-4f3d-8afe-52c3ec7f534f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37597744","allele":{"id":"https://genegraph.clinicalgenome.org/r/38faa482-42ac-427a-a0d0-c978bad17459"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/1c08ceb9-91e5-4f3d-8afe-52c3ec7f534f","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1c08ceb9-91e5-4f3d-8afe-52c3ec7f534f_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/3ec777aa-af6a-4cc6-ace1-b22e4b493457_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3ec777aa-af6a-4cc6-ace1-b22e4b493457_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f72900d8-8951-492c-9e11-5e275409ff1e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/37d127b9-0e1a-4605-9a84-97c86869df8f","type":"Finding","dc:description":"Absence of MSH3 expression was observed by immunohistochemistry assay, in both tissue from normal colon mucosa, and tissue from colon adenoma, from an individual (1275.1) with attenuated familial adenomatous polyposis (FAP) and biallelic LoF MSH3 variants. Same result (absence of MSH3 expression) was observed in colon adenoma from another, unrelated individual (1661.1) with FAP and biallelic LoF MSH3 variants. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476653","rdfs:label":"Immunohistochemistry assay (Figure 4)","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4ac85209-3003-4116-b9d3-3462728d27ff","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f8ecf60e-b7f3-45f7-bc4d-96eca71176dc","type":"Finding","dc:description":"When HCT116+3+5 was compared with HCT116+3 (this is the MSH3-deficient cell line), the presence of MSH3 significantly correlated with stabilization of the EMAST loci MYCL1 (P<0.0001) and D9S242 (P=0.047), and strongly correlated with stabilization of D19S394 (P=0.054) (Table 1; Supplementary Table S1). These results indicate that restoration of the expression of MSH3 by chromosome 5 transfer into HCT116+3 is associated with stabilization of EMAST loci.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18922920","rdfs:label":"Experimental Data MSH3 expression effect on MSI","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c629a7e5-94f0-45b4-b563-601479403b18","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fc948ab3-2f90-4846-82b2-6d88f2eb45c5","type":"Finding","dc:description":"Mutations in MSH2 are associated with Lynch syndrome and hereditary non-polyposis colorectal cancer (HNPCC). MSH2 and MSH3 dimerize to make the hMutS-beta complex, which binds to DNA mismatches (especially extrahelical loops. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8805365","rdfs:label":"Co-immunoprecipitation assay (fig 2)","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9a3d3ced-3665-424e-b88c-b0597268830e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c22f3a06-d00e-4451-885e-8fe0e7909fbf","type":"Finding","dc:description":"Band shift assay (Figure 3) shows MSH3-MSH2 dimer has bound mismatched DNA substrate.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8805365","rdfs:label":"Band shift assay (Figure 3)","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3ec777aa-af6a-4cc6-ace1-b22e4b493457_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2f112dab-7074-4b1f-aa49-2a82c16c94ee","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5657f88a-7320-4060-ac00-1b134a13419b","type":"FunctionalAlteration","dc:description":"Msh3−/− mouse embryonic fibroblasts displayed increased chromatid breaks and persistence of γH2AX foci following ionizing radiation, indicating a defect in DNA double strand break repair","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24013230","rdfs:label":"DNA double strand break repair assay (Figure 2)"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/638cc1ce-41f3-4935-8d78-fb1fce9988e5","type":"EvidenceLine","dc:description":"Awarding 1 point (instead of default 0.5 points) per GCEP recommendation.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/02da282e-8fc5-4d5f-8b97-844031c06580","type":"FunctionalAlteration","dc:description":"Biochemical mismatch repair assay was performed on extracts from wt mouse cells, MSH6-/- mouse cells, MSH3-/- mouse cells, and MSH3-/-/MSH6-/- ko. Ability to repair several types of mismatches was tested including base-base mismatches, single base insertion/deletions, two extra nucleotides. MSH3-/- cells had a partial repair defect compared to WT. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10706084","rdfs:label":"Mismatch repair assay (Figure 2)"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3ec777aa-af6a-4cc6-ace1-b22e4b493457_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/41dd6781-01bb-4374-9558-b894198dfca3","type":"EvidenceLine","dc:description":"Awarding 1 point (instead of default 2 points) per GCEP recommendation.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2933c2cd-ddf9-4237-9a84-053b9842f1a9","type":"Finding","dc:description":"Increased intestinal tumors in mice with MSH3 and MSH6 knocked out is similar to attenuated familial adenomatous polyposis phenotype in humans because it confers susceptibility to cancers and various proliferative disorders. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10545954","rdfs:label":"MSH3-/- / MSH6-/- mouse model (Table 1)","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/4f46cbec-3059-476c-b650-94328565d1c3","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8eec8064-c31a-463f-b87d-6ae8f9822034","type":"Finding","dc:description":"Increased tumor load in MSH3-/- mice is similar to human phenotype in that attenuated familial adenomatous polyposis confers susceptibility to various cancers and proliferative disorders. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10706084","rdfs:label":"MSH3-/- mice (Table 1)","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":8917,"specifiedBy":"GeneValidityCriteria10","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/cBzJDlBcDGQ","type":"GeneValidityProposition","disease":"obo:MONDO_0044300","gene":"hgnc:7326","modeOfInheritance":"obo:HP_0000007"},"version":"3.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_3ec777aa-af6a-4cc6-ace1-b22e4b493457-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}